Back pain laboratory findings
|
Back pain Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Lecture |
|
Case Studies |
|
Back pain laboratory findings On the Web |
|
American Roentgen Ray Society Images of Back pain laboratory findings |
|
Risk calculators and risk factors for Back pain laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Zehra Malik, M.B.B.S[2]
Overview
There are no diagnostic laboratory findings associated with back pain. However, to investigate the underlying cause of back pain it is crucial to look for the following, complete blood count (CBC), erythrocyte sedimentation rate, C-reactive protein, HLA-B27, antinuclear antibody (ANA), rheumatoid factor, lactate dehydrogenase (LDH), uric acid.
Laboratory Findings
There are no diagnostic laboratory findings associated with back pain. However, to investigate the underlying cause of back pain it is crucial to test for the following:
| Laboratory Test | Pathology Suspected |
| Complete blood count (CBC) | Infections, inflammation |
| Erythrocyte sedimentation rate | Infection, inflammation, arthritis[1] |
| C-reactive protein | Inflammation, arthritis[2] |
| HLA-B27 | Ankylosing spondylitis, reactive arthritis[3] |
| Rheumatoid factor | Rheumatoid arthritis[4] |
| Lactate dehydrogenase (LDH) | Rapid marrow turnover[5] |
| Uric acid | Rapid marrow turnover[5] |
References
- ↑ Harrison M (2015). "Erythrocyte sedimentation rate and C-reactive protein". Aust Prescr. 38 (3): 93–4. doi:10.18773/austprescr.2015.034. PMC 4653962. PMID 26648629.
- ↑ Sproston NR, Ashworth JJ (2018). "Role of C-Reactive Protein at Sites of Inflammation and Infection". Front Immunol. 9: 754. doi:10.3389/fimmu.2018.00754. PMC 5908901. PMID 29706967.
- ↑ McMichael A, Bowness P (2002). "HLA-B27: natural function and pathogenic role in spondyloarthritis". Arthritis Res. 4 Suppl 3: S153–8. doi:10.1186/ar571. PMC 3240147. PMID 12110134.
- ↑ Ingegnoli F, Castelli R, Gualtierotti R (2013). "Rheumatoid factors: clinical applications". Dis Markers. 35 (6): 727–34. doi:10.1155/2013/726598. PMC 3845430. PMID 24324289.
- ↑ 5.0 5.1 Ejaz AA, Pourafshar N, Mohandas R, Smallwood BA, Johnson RJ, Hsu JW (2015). "Uric acid and the prediction models of tumor lysis syndrome in AML". PLoS One. 10 (3): e0119497. doi:10.1371/journal.pone.0119497. PMC 4361475. PMID 25775138.